Abstract
Malignant tumors of the thyroid are rare, with an incidence of 1–2 cases per 100,000 people. Thyroid lymphomas comprise less than 5% of thyroid malignancies and 2% of all malignant lymphomas. The majority of thyroid lymphomas are non-Hodgkin’s lymphomas of B-cell origin, although a variety of histological subtypes are seen. The most common type is a diffuse large B-cell lymphoma accounting for 68% of cases. Follicular lymphomas and marginal zone, also known as mucosa-associated lymphatic tissue (MALT), lymphomas each account for approximately 10% of lymphomas and tend to have a much more indolent course and better prognosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Seer STAT fact sheet: Thyroid Seer. cancer gov accessed april 20, 2012
Doria R, Jekel JF, Cooper DL (1994) Thyroid lymphoma. The case for combined modality therapy. Cancer 73(1):200–206
Compagno J, Oertel JE (1980) Malignant lymphoma and other lymphoproliferative disorders of the thyroid gland. A clinicopathologic study of 245 cases. Am J Clin Pathol 74(1):1–11
Samaan NA, Ordonez NG (1990) Uncommon types of thyroid cancer. Endocrinol Metab Clin North Am 19(3):637–648
Derringer GA, Thompson LD, Frommelt RA et al (2000) Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 24(5):623–639
Ansell SM, Grant CS, Habermann TM (1999) Primary thyroid lymphoma. Semin Oncol 26(3):316–323
Graff-Baker A, Roman SA, Thomas DC et al (2009) Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery 146(6):1105–1115
Mack LA, Pasieka JL (2007) An evidence-based approach to the treatment of thyroid lymphoma. World J Surg 31(5):978–986
Pasieka JL (2000) Hashimoto’s disease and thyroid lymphoma: role of the surgeon. World J Surg 24(8):966–970
Thieblemont C, Mayer A, Dumontet C et al (2002) Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 87(1):105–111
Onal C, Li YX, Miller RC et al (2011) Treatment results and prognostic factors in primary thyroid lymphoma patients: a Rare Cancer Network study. Ann Oncol 22:156–164
Holm LE, Blomgren H, Lowhagen T (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312(10):601–604
Matsuzuka F, Miyauchi A, Katayama S et al (1993) Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 3(2):93–99
Meyer-Rochow GY, Sywak MS, Reeve TS et al (2008) Surgical trends in the management of thyroid lymphoma. Eur J Surg Oncol 34(5):576–580
Herrmann R, Panahon AM, Barcos MP et al (1980) Gastrointestinal involvement in non-Hodgkin’s lymphoma. Cancer 46(1):215–222
Tupchong L, Hughes F, Harmer CL (1986) Primary lymphoma of the thyroid: clinical features, prognostic factors, and results of treatment. Int J Radiat Oncol Biol Phys 12(10):1813–1821
Krueger GR, Medina JR, Klein HO et al (1983) A new working formulation of non-Hodgkin’s lymphomas. A retrospective study of the new NCI classification proposal in comparison to the Rappaport and Kiel classifications. Cancer 52(5):833–840
Skarsgard ED, Connors JM, Robins RE (1991) A current analysis of primary lymphoma of the thyroid. Arch Surg 126(10):1199–1203, discussion 1203–1204
Harris NL, Jaffe ES, Stein H et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84(5):1361–1392
Ishikawa H, Tamaki Y, Takahashi M et al (2002) Comparison of primary thyroid lymphoma with anaplastic thyroid carcinoma on computed tomographic imaging. Radiat Med 20(1):9–15
Goda JS, Gospodarowicz M, Pintilie M et al (2010) Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 116(16):3815–3824
Tsang RW, Gospodarowicz MK, Sutcliffe SB et al (1993) Non-Hodgkin’s lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group. Int J Radiat Oncol Biol Phys 27(3):599–604
Fisher RI, Gaynor ER, Dahlberg S et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328(14):1002–1006
DiBiase SJ, Grigsby PW, Guo C et al (2004) Outcome analysis for stage IE and IIE thyroid lymphoma. Am J Clin Oncol 27(2):178–184
Ha CS, Shadle KM, Medeiros LJ et al (2001) Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer 91(4):629–635
Miller TP, Dahlberg S, Cassady JR et al (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. N Engl J Med 339(1):21–26
Horning SJ, Weller E, Kim K et al (2004) Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin’s lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 22(15):3032–3038
Reyes F, Lepage E, Ganem G et al (2005) ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 352(12):1197–1205
Persky DO, Unger JM, Spier CM et al (2008) Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. J Clin Oncol 26(14):2258–2263
Pfreundschuh M, Schubert J, Ziepert M et al (2008) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 9(2):105–116
Jonak C, Troch M, Mullauer L et al (2010) Rituximab plus dose-reduced cyclophosphamide, mitoxantrone, vincristine, and prednisolone are effective in elderly patients with diffuse large B-cell lymphoma of the thyroid. Thyroid 20(4):425–427
Udelsman R, Chen H (1999) The current management of thyroid cancer. Adv Surg 33:1–27
Cha C, Chen H, Westra WH, Udelsman R (2002) Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration? Ann Surg Oncol 9(3):298–302
Rosen IB, Sutcliffe SB, Gospodarowicz MK et al (1988) The role of surgery in the management of thyroid lymphoma. Surgery 104(6):1095–1099
Pyke CM, Grant CS, Habermann TM et al (1992) Non-Hodgkin’s lymphoma of the thyroid: is more than biopsy necessary? World J Surg 16(4):604–609, discussion 609–610
Sippel RS, Gauger PG, Angelos P et al (2002) Palliative thyroidectomy for malignant lymphoma of the thyroid. Ann Surg Oncol 9(9):907–911
Wirtzfeld DA, Winston JS, Hicks WL Jr, Loree TR (2001) Clinical presentation and treatment of non-Hodgkin’s lymphoma of the thyroid gland. Ann Surg Oncol 8(4):338–341
Pedersen RK, Pedersen NT (1996) Primary non-Hodgkin’s lymphoma of the thyroid gland: a population based study. Histopathology 28(1):25–32
Sun TQ, Zhu XL, Wang ZY et al (2010) Characteristics and prognosis of primary thyroid non-Hodgkin’s lymphoma in Chinese patients. J Surg Oncol 101(7):545–550
Klyachkin ML, Schwartz RW, Cibull M et al (1998) Thyroid lymphoma: is there a role for surgery? Am Surg 64(3):234–238
Belal AA, Allam A, Kandil A et al (2001) Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma. Am J Clin Oncol 24(3):299–305
Laing RW, Hoskin P, Hudson BV et al (1994) The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 6(5):300–304
Willis RA (1931) Metastatic tumours in the thyroid gland. Am J Pathol 7(3):187–208 3
Lin JD, Weng HF, Ho YS (1998) Clinical and pathological characteristics of secondary thyroid cancer. Thyroid 8(2):149–153
Michelow PM, Leiman G (1995) Metastases to the thyroid gland: diagnosis by aspiration cytology. Diagn Cytopathol 13(3):209–213
Lin SY, Sheu WH, Chang MC et al (2002) Diagnosis of thyroid metastasis in cancer patients with thyroid mass by fine needle aspiration cytology and ultrasonography. Zhonghua Yi Xue Za Zhi (Taipei) 65(3):101–105
Watts NB (1987) Carcinoma metastatic to the thyroid: prevalence and diagnosis by fine-needle aspiration cytology. Am J Med Sci 293(1):13–17
Lam KY, Lo CY (1998) Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients. Arch Pathol Lab Med 122(1):37–41
Chen H, Nicol TL, Udelsman R (1999) Clinically significant, isolated metastatic disease to the thyroid gland. World J Surg 23(2):177–180, discussion 181
Wood K, Vini L, Harmer C (2004) Metastases to the thyroid gland: the Royal Marsden experience. Eur J Surg Oncol 30(6):583–588
Duggal NM, Horattas MC (2008) Metastatic renal cell carcinoma to the thyroid gland. Endocr Pract 14(8):1040–1046
Sindoni A, Rizzo M, Tuccari G et al (2010) Thyroid metastases from renal cell carcinoma: review of the literature. Scientific World Journal 10:590–602
Iesalnieks I, Winter H, Bareck E et al (2008) Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients’ survival. Thyroid 18(6):615–624
Cichon S, Anielski R, Konturek A et al (2006) Metastases to the thyroid gland: seventeen cases operated on in a single clinical center. Langenbecks Arch Surg 391(6):581–587
Kung B, Aftab S, Wood M, Rosen D (2009) Malignant melanoma metastatic to the thyroid gland: a case report and review of the literature. Ear Nose Throat J 88(1):E7
Mattavelli F, Collini P, Pizzi N et al (2009) Thyroid as a target of metastases: a case of metastatic seminoma in a patient who died of a second cancer. Tumori 95(1):91–93
Stoll L, Mudali S, Ali SZ (2010) Merkel cell carcinoma metastatic to the thyroid gland: aspiration findings and differential diagnosis. Diagn Cytopathol 38(10):754–757
Cheung WY, Brierley J, Mackay HJ (2008) Treatment of rectal cancer metastases to the thyroid gland: report of two cases. Clin Colorectal Cancer 7(4):280–282
Selimoglu H, Duran C, Saraydaroglu O et al (2007) Prostate cancer metastasis to thyroid gland. Tumori 93(3):292–295
Kihara M, Yokomise H, Yamauchi A (2004) Metastasis of renal cell carcinoma to the thyroid gland 19 years after nephrectomy: a case report. Auris Nasus Larynx 31(1):95–100
Nakhjavani MK, Gharib H, Goellner JR, van Heerden JA (1997) Metastasis to the thyroid gland. A report of 43 cases. Cancer 79(3):574–578
Rosen IB, Walfish PG, Bain J, Bedard YC (1995) Secondary malignancy of the thyroid gland and its management. Ann Surg Oncol 2(3):252–256
Papi G, Fadda G, Corsello SM et al (2007) Metastases to the thyroid gland: prevalence, clinicopathological aspects and prognosis: a 10-year experience. Clin Endocrinol (Oxf) 66(4):565–571
Calzolari F, Sartori PV, Talarico C et al (2008) Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Res 28(5B):2885–2888
Hacker U, Lenz G, Brehm G et al (2003) Metastasis of a rectal adenocarcinoma to the thyroid gland: diagnostic and therapeutic implications. Anticancer Res 23(6D):4973–4976
Heffess CS, Wenig BM, Thompson LD (2002) Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases. Cancer 95(9):1869–1878
Acknowledgements
We would like to thank Dr. Josephine Harter from the Department of Pathology at the University of Wisconsin for obtaining the histology figures.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sippel, R.S., Chen, H. (2012). Thyroid Lymphoma and Other Metastatic Lesions. In: Oertli, D., Udelsman, R. (eds) Surgery of the Thyroid and Parathyroid Glands. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-23459-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-23459-0_20
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-23458-3
Online ISBN: 978-3-642-23459-0
eBook Packages: MedicineMedicine (R0)